Paul Silva bought $100K of Rapport Therapeutics stock
By AlphaYouPublished Form 4
Silva Paul M
Reporting filer
Paul Silva reported buying 3,680 shares of Rapport Therapeutics, Inc. for about $100K ($27.07 a share on average). Form 4 filed Oct 22, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 22, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Silva Paul M | 2026-10-22 | P | Purchase | 3680 | 27.075 | 3,680 | 0 days | Filed terms
|
Common Stock
- Owner
- Silva Paul M
- Date
- 2026-10-22
- Code
- P
- Action
- Purchase
- Quantity
- 3680
- Price
- 27.075
- Following holdings
- 3,680
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-22
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 3680
- transaction Price Per Share: 27.075
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 3680
- direct Or Indirect Ownership: I
- nature Of Ownership: By Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Silva Paul M: Director.
Original sources
Prepared automatically from public filing data. Report a correction.